Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia
Clinical trial NCT06769490 · RECRUITING
Trial details
- NCT number
- NCT06769490
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-10
- Primary completion
- 2028-09-15
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.